跳至主要内容
临床试验/ACTRN12618001287224
ACTRN12618001287224已完成2 期

The effects of zolpidem on OSA severity

euroscience Research Australia (NeuRA)0 个研究点目标入组 20 人开始时间: 2018年7月31日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 64 Years(—)
性别
All

入选标准

  • Otherwise healthy, men and women with obstructive sleep apnoea
  • Patients who have a low-moderate respiratory arousal threshold (between zero and -25cmH2O epiglottic pressure just prior to arousal) as estimated from their baseline sleep study.

排除标准

  • Patients with confirmed overnight blood oxygen saturation nadir (SaO2) less than 70% from baseline sleep study
  • Patients who are estimated to have a high arousal threshold (less than -25cmH2O epiglottic pressure prior to arousal)
  • Women lactating, pregnant or of childbearing potential who are not willing to avoid becoming pregnant during the study.
  • -Patients with any other medical condition which may interfere in the evaluation of the study.
  • -Patients with a previous history of addiction to alcohol or drugs.
  • -Patients taking medications known to affect sleep or muscle activity.

研究者

发起方
euroscience Research Australia (NeuRA)

相似试验